Bill of Health

JUNE 26, 2023

Once approved by the FDA, CalRx insulin will be made available at $30 to all Californians who need it. This initiative will come with enormous savings to the public: it will bring down the price of insulin by 90%, saving cash-paying patients between $2,000 to $4,000 annually.

Pharmaceutical Industry 195

Pharmaceutical Industry Governance FDA Public Health 195

HIT Consultant

FEBRUARY 1, 2024

Mike Szczesny, Owner & VP of EDCO Awards & Specialties Influencer marketing in the pharmaceutical industry is a complex issue with reasonable arguments on multiple sides. Their role extends beyond simple promotion—influencing public opinions, driving awareness, and ultimately facilitating a positive impact on public health.

Pharmaceutical Industry 111

Pharmaceutical Industry FDA Public Health Regulatory Compliance 111

Bill of Health

SEPTEMBER 28, 2023

Senator Sanders’ proposal within PAHPA was ultimately struck from the next iteration of the legislation due to concerns from the pharmaceutical industry and others that such a measure would chill innovation. Federal support by BARDA and the CDC have de-risked the development of medical products for the pharmaceutical industry.

COVID-19 208

COVID-19 COVID-19 Vaccine Pharmaceutical Industry Governance 208

SQA

AUGUST 2, 2021

This technical report focuses on the challenges facing the pharmaceutical industry that use complex packaging systems for sterile drugs and biologics (e.g., Led by the FDA and ASPR, the White House report and its recommendations ( report PDF ) have been accepted by President Biden. United States FDA – Guidances for Devices.

FDA 83

FDA COVID-19 Pharmaceutical Industry Hospitals 83

Hall Render

FEBRUARY 18, 2022

Lawmakers call on Biden to end public health emergency. Meet new FDA chief Dr. Robert Califf: 5 things to know. Outpatient push being felt in architecture industry. 5 recent hospital, health system COO moves. of Public Health website. 8 recent hospital, health system executive resignations.

COVID-19 40

COVID-19 Nursing Homes Nurses COVID-19 Vaccine 40

Bill of Health

SEPTEMBER 12, 2023

By James René Jolin and Susannah Baruch On July 13, 2023, the United States Food and Drug Administration (FDA) approved Opill (norgestrel) as the first daily oral contraceptive available for non-prescription use in the U.S. James René Jolin (JRJ): This recent move by the FDA is one without precedent. It was a long time coming.

FDA 189

FDA Pharmaceutical Industry COVID-19 Public Health 189

Health Populi

SEPTEMBER 19, 2018

This short-term fiscal choice by the health consumer can lead to longer-term poor physical outcomes for the person-as-patient. Health Populi’s Hot Points: And now, to reputation risk. consumers have long-ranked the pharmaceutical industry relatively low, but above car salespeople and the Federal government.

Pharmaceutical Industry 54

Pharmaceutical Industry Hospitals Governance FDA 54